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Figure. Huge left atrial myxoma (measuring 4.0 × 3.5 cm) occupying almost the whole atrial cavity. Note the warty 
appearance of the tumor surface. The left atrial appendage (arrowhead) is open and does not show thrombosis.
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Primary cardiac tumors (PCT) are rare, accounting 
for 0.0017-0.03% in autopsy series,1,2 in contrast to 
metastatic tumors of the heart, which are 30 times 
more frequent.3,4 Nearly 75% of PCT are benign and 
most often represented by a myxoma in 50% of cases 
in the adult population.5
The World Health Organization defines a cardiac 
myxoma (CM) as a neoplasm composed of stellate to 
plump, cytologically bland, mesenchymal cells set in 
a myxoid stroma.6
Approximately 95% of CMs occurs isolated 
in a wide range of age. However, they occur more 
frequently among women in the fifth or sixth decade 
of life.7-9
For a time, myxomas were believed to arise from 
endocardial thrombi10 and some evidence suggests an 
association with Herpes simplex virus 1 infections11; 
however, their tumoral histogenesis remains unknown. 
Meanwhile, ultrastructure analysis—added to 
immunohistochemical investigation—suggests that CM 
is more likely derived from a pluripotent mesenchymal 
stem cell or sub-endothelial cell. Chromosomal clonal 
abnormalities, mostly on chromosome 2, 12, and 17, 
appear to be implicated in the myxoma formation, 
although defects on chromosome 1q32, the loss of 
the Y chromosome, and the telomeric association of 
chromosome 13 and 15, have also been involved.12-14
CMs are mostly pedunculated and solitary, and 
arise primarily adjacent to the lamina of the fossa ovalis 
(corresponding to the embryonic septum primum) and 
develop in the left atrium in 75% of cases, followed by 
the right atrium (18%),15 the right and left ventricles 
(3% in each), and the valves (1%).15-20 Multiple 
myxomas represent 5% of the cases, half of which 
are of bilateral origin.21
Although CM is a benign tumor, reports on 
its malignancy are well-known, which include: 
(i) local relapse; (ii) local invasiveness; and (iii) distant 
metastasis.12 The potential for malignant transformation 
is controversial, despite the publication of some reports 
of sarcomas arising from CM recurrences.22,23
Clinical manifestations of CMs are protean and 
may vary from asymptomatic cases (with a tumor 
< 4 cm) to unexpected sudden death (generally 
caused by blood flow obstruction or embolization). 
In most cases, the clinical presentation will depend on 
the tumor size, mobility, and location. One or more 
symptoms of the following triad will usually be present: 
(i) embolic phenomena (present in 30-40% of cases 
and usually associated with a villous surface of the 
tumour)24; (ii) intracardiac flow obstruction (present in 
almost 50% of cases); and (iii) constitutional symptoms 
(present in 20-60% of cases). In general, the most 
common signs and symptoms are non-specific and 
include dyspnea, palpitation (due to atrial fibrillation), 
lower limbs edema, hepatomegaly, angina, syncope, 
cough, and pulmonary edema. The constitutional 
symptoms, characterized by fatigue, fever, myalgia, 
arthralgia, and weight loss, are probably related to 
interleukin-6 cytokine production.25
The  d iagnos i s  o f  a  CM i s  mos t l y  done 
with echocardiography, both transthoracic and 
transesophageal, which represent the imaging 
modality of choice, although the latter permits precise 
information for the scheduling of surgery. Due to the 
rarity and consequent unfamiliarity of most general 
practitioners with this entity, CMs are sometimes 
misdiagnosed. Differential diagnosis should include 
intracardiac thrombus and other cardiac tumors.
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